Health and Human Services officials are questioning the methodology used in a COVID vaccine study. The report, which was slated to appear in a Centers for Disease Control and Prevention Morbidity and ...
Long COVID affects up to 18 million Americans, yet research funding remains inadequate. Experts call for aggressive NIH investment in novel treatments.
Houman Hemmati, a board-certified ophthalmologist, biotech executive and frequent Fox News guest, is a candidate to become the US’ top vaccine and gene therapy regulator, according to senior ...
(THE HILL) — The Centers for Disease Control and Prevention (CDC) reportedly delayed the publication of its report detailing the benefits of the COVID-19 vaccine at the behest of its acting director.